DaPeCa‐1: diagnostic accuracy of sentinel lymph node biopsy in 222 patients with penile cancer at four tertiary referral centres – a national study from Denmark

Authors:

Abstract
Objectives: To estimate the diagnostic accuracy of sentinel lymph node biopsy ( SNB ) in patients with penile cancer and assess SNB complications in a national multicentre setting. Patients and methods: Retrospectively data were collected from records in four university centres by one medical doctor covering all SNB s performed in Denmark between 1 January 2000 and 31 December 2010. Patients had either impalpable lymph nodes ( LN s) in one or both groins, or had a palpable inguinal mass from which aspiration cytology failed to reveal malignancy. Patients were injected with nanocolloid technetium and had a scintigram recorded before the SNB . The primary endpoint was LN recurrence on follow‐up. The secondary endpoint was complications after SNB . Diagnostic accuracy was computed. Results: In all, 409 groins in 222 patients were examined by SNB . The median (interquartile range) follow‐up of patients who survived was 6.6 (5–10) years. Of 343 negative groins, eight were false negatives. The sensitivity was 89.2% (95% confidence interval 79.8–95.2%) per groin. Interestingly, four of 67 T1G1 patients had a positive SNB . In all, 28 of 222 (13%) patients had complications of Clavien‐Dindo grade I– III a. Conclusion: Penile cancer SNB with a close follow‐up stages LN involvement reliably and has few complications in a national multicentre setting. Inguinal LN dissection was avoided in 76% of patients.
Funding Information
  • Aarhus Universitet

This publication has 20 references indexed in Scilit: